Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine prophylaxis for subconjunctival hemorrhage in 23G vitrectomy
2012-002895-15Phase 3Completed
- Sponsor
- Fundación Oftalmológica del Mediterráneo
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of brimonidine in subconjunctival hemorrhage (SCH) (2 arms), sponsored by Fundación Oftalmológica del Mediterráneo. Primary endpoint: Number of quadrants with subconjunctival hemorrhage. Started Sep 2012; status: completed.
02
Drugs
brimonidine
03
Conditions
subconjunctival hemorrhage (SCH)
Beyond the preview
Go deeper on 2012-002895-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002895-15.